Concepedia

Till Geib

TG

Statistics

Publications

10

Citations

490

H-Index

10

Active since

2000

Affiliations

AbbVie (United States)(Current)

Allergan (United States)

Yale New Haven Hospital

Ghent University Hospital

Texas Children's Hospital

Till Geib is an author at AbbVie (United States) specializing in life sciences, pharmacotherapy, and molecular virology.

Publications per year

2000–2023

10

Publications

10

IL-6 Receptor Independent Stimulation of Human gp130 by Viral IL-6

Jürgen Müllberg, Till Geib, Thomas Jostock et al. · The Journal of Immunology · 2000 · 110 citations · Full text

, , +17

Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs

Csilla Madocsai, Sharlene Lim, Till Geib et al. · Molecular Therapy · 2005 · 90 citations · Full text

, , +16

Selective Virus Resistance Conferred by Expression of Borna Disease Virus Nucleocapsid Components

Till Geib, Christian Sauder, Sascha Venturelli et al. · Journal of Virology · 2003 · 77 citations · Full text

, , +17

Human herpes virus 8 interleukin‐6 homologue triggers gp130 on neuronal and hematopoietic cells

Susanne H. Hoischen, Petra Vollmer, Pia März et al. · European Journal of Biochemistry · 2000 · 53 citations · Full text

, , +15

Restoration of Full-Length SMN Promoted by Adenoviral Vectors Expressing RNA Antisense Oligonucleotides Embedded in U7 snRNAs

Till Geib, Klemens J. Hertel · PLoS ONE · 2009 · 47 citations · Full text

, , +13

1–5 of 10